Announcement for the subscription payment period and tentative underwriting price for cash capital increase before IPO.

1. Date of occurrence of the event:2023/08/25
2. Company name:Diamond Biofund Inc.
3. Relationship to the Company (please enter ”head office” or”subsidiaries”):Head office.
4. Reciprocal shareholding ratios:N/A
5. Cause of occurrence:Announcement for the subscription payment period and tentative underwriting price for cash capitalincrease before IPO.
6. Countermeasures:None.
7. Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):

(1)The Company’s public underwriting of cash capital increase beforethe initial listing, 100,000 thousand common shares with par value of NT$10 and NT$1,000,000 thousand in total, has been declared effective by Taiwan Stock Exchange Corporation on 2023/08/02 in the official letter No.1121803660.

(2)In accordance with Article 267 of the Company Act, 15% of the new issued common shares (15,000 thousand shares) will be reserved for subscription by employees. According to Article 28-1 of the Securities and Exchange Act and resolutions of 2022/06/27 Extraordinary Shareholders’ Meeting, the remaining 85% of the new issued common shares (85,000 thousand shares) will be subscribed by the public. The Chairman is authorized to allocate shares unsubscribed by employees to specific parties. It is planned to process the shares unsubscribed by the public according to the Taiwan Securities Association Rules Governing Underwriting and Resale of Securities by Securities Firms.

(3)The underwriting of cash capital increase through issuance of common shares before IPO was conducted by competitive auction and public subscription at the same time. And the upper limit of minimum underwriting price of the competitive auction is calculated as 70 percent of the simple arithmetic mean of the average trade prices, after factoring out ex-rights trading in connection with issuance of stock dividends (or ex-rights trading in connection with capital reduction) and ex-dividend trading, of the 30 business days on which trades are executed before the filing of the competitive auction agreement to the Taiwan Securities Association. The tentative underwriting price is set at NT$37.74 per share (the minimum price of competitve aution). Securities shall be awarded on the basis of bid price in descending order, and each successful bidder shall subscribe the securities at the bidder’s own bid price. The public subscription price is calculated as the weighted average of the bid price of all successful bids, and its upper limit is set as 1.06 times of the minimum underwriting price, so the tentative underwriting price is determined to be issued with a premium at NT$40 per share.

(4)The purpose of this cash capital increase is to reinvest the large-scaled investment company.

(5)The subscription payment period for cash capital increase:

a.The period for competitive auction:2023/08/30~2023/09/01

b.The period for public subscription:2023/09/07~2023/09/11

c.The payment period for subscription by employees: 2023/09/07~2023/09/12

d.The date of funds deducted for competitive auction:2023/09/08

e.The date of funds deducted for public subscription:2023/09/12

f.The payment period for subscription by specific parties: 2023/09/13~2023/09/15

g.The record date of cash capital increase:2023/09/15

(6)The new issued common shares of this cash capital increase are non-physical shares, and their rights and obligations are the same as the current issued common shares.